WO2003079899A1 - Vorrichtung und verfahren zur messung von inhaltsstoffen im blut - Google Patents
Vorrichtung und verfahren zur messung von inhaltsstoffen im blut Download PDFInfo
- Publication number
- WO2003079899A1 WO2003079899A1 PCT/DE2003/000372 DE0300372W WO03079899A1 WO 2003079899 A1 WO2003079899 A1 WO 2003079899A1 DE 0300372 W DE0300372 W DE 0300372W WO 03079899 A1 WO03079899 A1 WO 03079899A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- radiation
- sensors
- blood
- measurement
- determined
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
Definitions
- the invention relates to a method for controlling a device for measuring a proportion of constituents in the blood, in which electromagnetic radiation with different radiation frequencies is passed through a vessel containing the blood and in which at least some of the radiation emerging from the vessel is sensed and one Evaluation is forwarded.
- the invention also relates to a device for measuring a proportion of the amount of constituents in the blood, which has at least one emission source for generating electromagnetic radiation and at least one sensor for detecting a transmission portion of the radiation, which sensor is connected to an evaluation device.
- a device for determining concentrations of certain portions in the blood is determined, in which part of the living organism is irradiated with light from a light source and a portion of the light penetrating the organism is measured by measurement technology and fed to an evaluation becomes.
- a comparable process is also described in PCT-O 00/42905.
- a further arrangement is known from PCT-WO 99/39631, here a measuring arrangement is positioned in the area of an index finger, which shines through the finger with a plurality of light sources and in which reflection components are determined. Similar arrangements for the metrological detection of portions in the blood in which a finger is used as the measuring point are also explained in US Pat. No. 60 64 898 and US Pat.
- a device for measuring the hemoglobin concentration in the blood is described in DE-PS 196 12 425 and a further device for measurement technology application in the area of the finger is explained in PCT-WO 89/01758.
- a measuring device for the non-invasive determination of the hemoglobin content in the blood is already known from the publication "Annual Meeting of the Society for Biomedical Measurement Technology e.V., September 28-30, 2000 in Lübeck, Volume 45, Kraitl, Behrens, Hornberger, Gehring".
- This object is achieved in that at least two sensors for radiation detection are positioned at a local distance relative to one another and in that the evaluation is assigned a calibration characteristic curve which is determined by an individual calibration measurement, in which at least one constant is used as the calibration criterion, of at least one a measured value variable detected by the sensors is determined.
- Another object of the present invention is to design a device of the type mentioned in the introduction. structure that an improved measurement quality is achieved.
- the evaluation device has at least two sensors and that the evaluation device has an analyzer for determining the angle-dependent scattering of the radiation by evaluating the received signals of the individual sensors.
- the individual detection of the tissue-dependent scatter makes it possible to achieve a significant increase in measuring accuracy.
- the expenditure on equipment is increased only insignificantly. There is no extension of the measuring time.
- a particularly reliable measurement of the scatter can be achieved by using at least three receiving elements.
- a particularly simple measurement setup can be achieved by using electromagnetic radiation in the visible and infrared frequency range.
- the methodology of multi-wave pulse spectroscopy can be used to carry out the measurement.
- a patient-specific calibration without extending the measurement time of a blood parameter can be carried out by measuring a spatial scattering of the radiation. For this purpose, it is necessary that the scatter is determined by detecting a radiation intensity that deviates from a main radiation direction.
- a particularly simple evaluation criterion can be implemented in that the scatter is determined by examining the pulse-cyclic signals of the measured values of the individual sensors.
- a preferred application is that an oxygen content in the blood is determined.
- an oxygen concentration is determined relative to a reference value in the blood.
- a symmetrical measurement setup can be achieved in that the sensors have essentially the same distances relative to one another.
- This structure is a special case of a general arrangement in which this condition does not apply.
- FIG. 1 is a schematic diagram of a measuring arrangement
- FIG. 3 shows a schematic block diagram to illustrate the measurement of a hemoglobin concentration or an oxygen saturation in the blood
- Fig. 6 a histogram of the measurement variable Omega for three measurement channels
- 11 shows a basic illustration to illustrate the determination of the values for omega, delta d and the concentration values as a function of the measured values recorded.
- FIG. 1 in which a cross section through a tissue (9) with vessels (1, 50) is shown, there are three sensors (2, 3, 4) and three emission sources in an environment of the blood-carrying tissue (9) (5, 6, 7) arranged.
- the emission sources (5, 6, 7) can be realized, for example, by light-emitting diodes or laser diodes. Photodiodes can be used as sensors (2, 3, 4).
- the emission sources (5, 6, 7) are connected to a multiplexer (8) for sequential control.
- the sensors (2, 3, 4) and the emission sources (5, 6, 7) are preferably arranged directly on an outer surface of the tissue (9) surrounding the vessel (1, 50).
- the sensors (2, 3, 4) are connected to an evaluation device (10) which is provided with an analyzer (11). Measurement results provided by the evaluation device (10) can be visualized or printed out in the area of a display device (12), and electronic transmission to devices for further measurement value processing is also possible.
- Fig. 2 shows a block diagram of the procedure for an individual calibration, a standard calibration function (13) initially a priori a patient-independent basic setting, which is then linked to a patient-specific with a scatter determination (14) when carrying out the measurement process Measuring device (15) is connected.
- the measuring device (15) detects the signals of those sensors (2, 3, 4) that are not assigned to a current main radiation direction of the assigned emission source (5, 6, 7).
- the results of the standard calibration function (13) and the initial value of the scattering determination (14) are linked to one another by a combiner (16) in accordance with a calculation rule specified as an individual calibration function.
- An output value of the combiner (16) is linked to a measured value variable (17) which is determined from the measured value of the sensor (2, 3, 4) which is in the main radiation direction of the assigned emission source (5, 6, 7) lies . Linking the output value of the combiner (16) and the measured value variable (17) gives the respective target variable (18).
- FIG. 3 shows a block diagram to explain an optical hemoglobin measurement in the blood in order to determine the oxygen content of the blood. It is measured here that hemoglobin with bound oxygen has a different optical absorption behavior than hemoglobin without bound oxygen.
- the block diagram according to FIG. 3 consists of two functional components according to FIG. 2.
- the arrangement of the standard calibration function (13), the scattering determination (14), the combiner (16) and the measured value variable (17) is a further arrangement of a standard calibration function (19), a scattering determination (20), a combiner (21) and a measured value variable (22) connected in parallel.
- the target variable (18) and a target variable (23) as the initial value of the second arrangement are in the range of one Link (24) merged, which provides a resulting target value (25) as a starting value.
- An absorption intensity (26) is plotted as a function of the respective wavelength (27).
- a first minimum is found at a wavelength of about 600 nanometers, then there is another rise to an intermediate maximum at about 900 nanometers, and then the course approaches the zero line asymptotically.
- the device according to the invention makes it possible to largely limit movement artifacts and sensor relocations, since in each case it is automatically calibrated to the new optical path. This makes it possible to use the device even with moving patients and to provide the attending physician with a decision basis for measures to be taken at short notice. It is taken into account here that rapid movements lead to a loss of measured values, but sensor rearrangements with phases of relative calm do not.
- different wavelengths can be specified.
- the emission characteristics can, for example, be bundled closely or implemented with a fanned out radiation lobe.
- the patient-specific calibration can be carried out either before the measurement is actually carried out or cyclically during the measurement.
- a cyclical determination in the course of the pulse spectroscopic measurement is particularly advantageous. This makes it possible to compensate for intentional or arterial changes in position of the optical sensors (2, 3, 4) or change of application location while the measurement is being carried out.
- pulse-spectroscopic measurement offers the advantage that measurement results from tissue and blood can be delivered with a high degree of measurement accuracy in a very short time and without invasive methods on the patient.
- the light energy detected by the sensors (2, 3, 4) has a pulse component and a constant component.
- the pulse component is a consequence of the pulse-cyclical change in the thickness of blood vessels.
- the direct component is the radiation component emerging after the tissue has passed through. The light energy changes depending on the lighting intensity due to the selected emission sources (5, 6, 7).
- a permissible transmission path length is in a range from 3 mm to 35 mm, preferably in a range from 5 mm to 30 mm and particularly preferably in a range from 7 mm to 25 mm.
- the number of emission elements is 7, preferably 4.
- emission elements e.g. 4x LED + 3x LASER, preferably 2x LED + 2x LASER and particularly preferably 4x LASER, can be used.
- the wavelengths in the area of the emission elements are 550 nm to 1,500 nm, preferably 620 nm to 1,350 nm and particularly preferably 660 nm to 1,300 nm.
- the solid angle positions of the emission elements are in a range of 1 ° to 179 °, preferably 75 ° to 125 ° and particularly preferably 85 ° to 95 °.
- the emission elements are preferably centered centrally via a main diode and particularly preferably laterally via secondary diodes. In principle, centering can also be omitted.
- the LEDs and / or LASERS are preferably focused with a flat plane and particularly preferably with a lens. In principle, focusing can also be omitted.
- the number of detector elements is in a range from 2 to 8, preferably 2 to 5 and particularly preferably 3.
- the solid angle position of the detection elements is in a range from -89 ° to + 89 °, preferably from -25 ° to + 35 ° and particularly preferably from -10 ° to + 10 °.
- the normals of the detector surface are centered preferably centrally with respect to the central emission and particularly preferably laterally with respect to the secondary emission.
- the size of the detector elements is in a range of 2 mm 2 to 10mm 2, preferably 2 mm 2 to 5 mm 2 and more preferably 3mm. 2
- plethysmograms are recorded on each photoreceiver for different wavelengths of emitted radiation.
- the wavelengths are taken from the VIS and the NIR / IR range of the electromagnetic radiation.
- a measurement variable ⁇ z is created for each photodiode Z by linking characteristic properties of these plethysmograms.
- pulse-oximetric measuring technology it is possible for a measured value variable ⁇ to be recorded and for this to be a priority ri defined calibration is assigned to the value of a 0 2 saturation.
- the process sequence according to the invention picks up all measured value variables ⁇ z and links them by means of a sensor-specific transfer function to form a new corrected measured value variable ⁇ CoIr - this measured value variable is also linked to the tissue-specific differential weakening ⁇ .
- tissue-specific differential attenuation ⁇ is a measure of the decrease in the radiation intensity within the measurement location. This weakening results from the examination of the differences of all absolute intensities at all z photo receivers.
- the photoreceivers are arranged in a geometrically sufficiently defined manner. For this reason, the changes in the absolute intensities are due to the different types of patient-specific light paths.
- the differential attenuation ⁇ follows from the absorption and deflection (scattering and refraction) of photons at the measurement location. The proportions from these individual processes do not have to be determined individually for the present method.
- the differential weakening ⁇ and the corrected measured value variable ⁇ z determine the target variable of the method, namely the arterial oxygen saturation, via the calibration function according to the invention.
- the PIC correction function is:
- variable ⁇ C ⁇ ⁇ r represents the resulting measured value variable, which is via the calibration function
- K lz , K 22 . and K 3z are validated and adjusted by an empirical (clinical) examination.
- the course of the calibration function g ( ⁇ C ⁇ rr) corresponds to the known, empirically determined calibration at the application sites of pulse oxy etry.
- Another preferred application of the invention is the non-invasive continuous determination of the hemoglobin concentration.
- the determination of the hemoglobin concentration is based on the patient-specific calibration PIC. Without this calibration, an absolute determination, i.e. a size with a physical unit of measure (here [mg / dl]) cannot be carried out with sufficient accuracy.
- the weakening of substance concentrations within a tissue can only be derived using the method of pulse spectroscopy via the product of the change in thickness and the substance concentration.
- Ij . and I 2 VIS / NIR / IR intensities after tissue passage ⁇ ( ⁇ ): wavelength-dependent extinctions of the substance derivatives X from S sX: saturation of the substance S with the derivative X.
- N number of the spectroscopically relevant substance derivatives at the measurement site
- the change in thickness on the pulsating vessels is associated with a pulse-cyclical change in transmission, which is the basis of every plethysmogram.
- the amplitude of plethysmograms is defined by three characteristics:
- the differentiation of the absorbance ⁇ ⁇ ( ⁇ ) from the vascular thickness change D is determined by an additional NIR / IR emission, the so-called reference measurement. werkstelligt. This NIR / IR emission to the measuring wavelength know where R ange no significant (concentration-dependent) absorption at the desired blood substances. Their absorption should primarily take place in water.
- the differential weakening ⁇ introduced under PIC is again recorded. This determines which signal change at the photoreceivers is caused by a specific change in the absorption.
- the hemoglobin concentration is now calculated from the given determination relationship on the basis of the known relative concentrations ( saturations).
- N Number of hemoglobin derivatives on the patient side
- ⁇ counting variable
- the hemoglobin measurement is thus accessible to a continuous, non-invasive measurement.
- the derivatives saX ⁇ are newly determined using the PlC methodology. This more precise method of determination is a prerequisite for a sufficiently precise determination of the substance concentration CHb sought.
- the determination relationship also includes the measurement of the attenuation ⁇ , which is also novel.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03704301A EP1487339A1 (de) | 2002-03-27 | 2003-02-08 | Vorrichtung und verfahren zur messung von inhaltsstoffen im blut |
AU2003206658A AU2003206658A1 (en) | 2002-03-27 | 2003-02-08 | Device and method for measuring constituents in blood |
US10/509,001 US7095491B2 (en) | 2002-03-27 | 2003-02-08 | Device and method for measuring constituents in blood |
CA002480260A CA2480260A1 (en) | 2002-03-27 | 2003-02-08 | Device and method for measuring blood constituents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10213692A DE10213692B4 (de) | 2002-03-27 | 2002-03-27 | Verfahren zur Steuerung einer Vorrichtung und Vorrichtung zur Messung von Inhaltsstoffen im Blut |
DE10213692.0 | 2002-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003079899A1 true WO2003079899A1 (de) | 2003-10-02 |
Family
ID=27815991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2003/000372 WO2003079899A1 (de) | 2002-03-27 | 2003-02-08 | Vorrichtung und verfahren zur messung von inhaltsstoffen im blut |
Country Status (6)
Country | Link |
---|---|
US (1) | US7095491B2 (de) |
EP (1) | EP1487339A1 (de) |
AU (1) | AU2003206658A1 (de) |
CA (1) | CA2480260A1 (de) |
DE (1) | DE10213692B4 (de) |
WO (1) | WO2003079899A1 (de) |
Families Citing this family (142)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914613A (en) | 1996-08-08 | 1999-06-22 | Cascade Microtech, Inc. | Membrane probing system with local contact scrub |
US6018673A (en) | 1996-10-10 | 2000-01-25 | Nellcor Puritan Bennett Incorporated | Motion compatible sensor for non-invasive optical blood analysis |
US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
US9042952B2 (en) | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US9468378B2 (en) | 1997-01-27 | 2016-10-18 | Lawrence A. Lynn | Airway instability detection system and method |
US20070191697A1 (en) | 2006-02-10 | 2007-08-16 | Lynn Lawrence A | System and method for SPO2 instability detection and quantification |
US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
US6256882B1 (en) | 1998-07-14 | 2001-07-10 | Cascade Microtech, Inc. | Membrane probing system |
US6675031B1 (en) | 1999-04-14 | 2004-01-06 | Mallinckrodt Inc. | Method and circuit for indicating quality and accuracy of physiological measurements |
US6914423B2 (en) | 2000-09-05 | 2005-07-05 | Cascade Microtech, Inc. | Probe station |
US6965226B2 (en) | 2000-09-05 | 2005-11-15 | Cascade Microtech, Inc. | Chuck for holding a device under test |
DE20114544U1 (de) | 2000-12-04 | 2002-02-21 | Cascade Microtech Inc | Wafersonde |
US20060195041A1 (en) | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
US8135448B2 (en) * | 2001-03-16 | 2012-03-13 | Nellcor Puritan Bennett Llc | Systems and methods to assess one or more body fluid metrics |
US6754516B2 (en) | 2001-07-19 | 2004-06-22 | Nellcor Puritan Bennett Incorporated | Nuisance alarm reductions in a physiological monitor |
WO2003052435A1 (en) | 2001-08-21 | 2003-06-26 | Cascade Microtech, Inc. | Membrane probing system |
US7006856B2 (en) | 2003-01-10 | 2006-02-28 | Nellcor Puritan Bennett Incorporated | Signal quality metrics design for qualifying data for a physiological monitor |
US7016715B2 (en) | 2003-01-13 | 2006-03-21 | Nellcorpuritan Bennett Incorporated | Selection of preset filter parameters based on signal quality |
US7492172B2 (en) | 2003-05-23 | 2009-02-17 | Cascade Microtech, Inc. | Chuck for holding a device under test |
US7057404B2 (en) | 2003-05-23 | 2006-06-06 | Sharp Laboratories Of America, Inc. | Shielded probe for testing a device under test |
US7250626B2 (en) | 2003-10-22 | 2007-07-31 | Cascade Microtech, Inc. | Probe testing structure |
US7187188B2 (en) | 2003-12-24 | 2007-03-06 | Cascade Microtech, Inc. | Chuck with integrated wafer support |
JP2007517231A (ja) | 2003-12-24 | 2007-06-28 | カスケード マイクロテック インコーポレイテッド | アクティブ・ウェハプローブ |
US7190985B2 (en) | 2004-02-25 | 2007-03-13 | Nellcor Puritan Bennett Inc. | Oximeter ambient light cancellation |
US7120479B2 (en) | 2004-02-25 | 2006-10-10 | Nellcor Puritan Bennett Inc. | Switch-mode oximeter LED drive with a single inductor |
US8611977B2 (en) * | 2004-03-08 | 2013-12-17 | Covidien Lp | Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue |
US7194293B2 (en) | 2004-03-08 | 2007-03-20 | Nellcor Puritan Bennett Incorporated | Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics |
US7534212B2 (en) | 2004-03-08 | 2009-05-19 | Nellcor Puritan Bennett Llc | Pulse oximeter with alternate heart-rate determination |
US7277741B2 (en) | 2004-03-09 | 2007-10-02 | Nellcor Puritan Bennett Incorporated | Pulse oximetry motion artifact rejection using near infrared absorption by water |
DE202005021435U1 (de) | 2004-09-13 | 2008-02-28 | Cascade Microtech, Inc., Beaverton | Doppelseitige Prüfaufbauten |
US7656172B2 (en) | 2005-01-31 | 2010-02-02 | Cascade Microtech, Inc. | System for testing semiconductors |
US7535247B2 (en) | 2005-01-31 | 2009-05-19 | Cascade Microtech, Inc. | Interface for testing semiconductors |
US7392075B2 (en) | 2005-03-03 | 2008-06-24 | Nellcor Puritan Bennett Incorporated | Method for enhancing pulse oximetry calculations in the presence of correlated artifacts |
AT501698B1 (de) * | 2005-03-18 | 2007-04-15 | Felix Dipl Ing Dr Himmelstoss | Vorrichtung zur mehrpulserfassung |
DE102005020022A1 (de) * | 2005-04-29 | 2006-11-09 | MCC Gesellschaft für Diagnosesysteme in Medizin und Technik mbH & Co. KG | Verfahren und Vorrichtung zur Multi-Wellenlängen Pulsspektroskopie |
US7725147B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for removing artifacts from waveforms |
US7725146B2 (en) | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for pre-processing waveforms |
US20070106126A1 (en) | 2005-09-30 | 2007-05-10 | Mannheimer Paul D | Patient monitoring alarm escalation system and method |
DE112006002808A5 (de) * | 2005-11-15 | 2008-09-04 | Weinmann Geräte für Medizin GmbH + Co. KG | Autoadaptive Kalibration |
US7668579B2 (en) | 2006-02-10 | 2010-02-23 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
US8702606B2 (en) | 2006-03-21 | 2014-04-22 | Covidien Lp | Patient monitoring help video system and method |
DE102007063934B3 (de) | 2006-04-07 | 2019-07-11 | Löwenstein Medical Technology S.A. | Vorrichtung zur Ermittlung von Biosignalen |
US7723999B2 (en) | 2006-06-12 | 2010-05-25 | Cascade Microtech, Inc. | Calibration structures for differential signal probing |
US7403028B2 (en) | 2006-06-12 | 2008-07-22 | Cascade Microtech, Inc. | Test structure and probe for differential signals |
US7764072B2 (en) | 2006-06-12 | 2010-07-27 | Cascade Microtech, Inc. | Differential signal probing system |
US8380271B2 (en) | 2006-06-15 | 2013-02-19 | Covidien Lp | System and method for generating customizable audible beep tones and alarms |
US20080012578A1 (en) * | 2006-07-14 | 2008-01-17 | Cascade Microtech, Inc. | System for detecting molecular structure and events |
US8064975B2 (en) | 2006-09-20 | 2011-11-22 | Nellcor Puritan Bennett Llc | System and method for probability based determination of estimated oxygen saturation |
US8696593B2 (en) | 2006-09-27 | 2014-04-15 | Covidien Lp | Method and system for monitoring intracranial pressure |
US7922665B2 (en) | 2006-09-28 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for pulse rate calculation using a scheme for alternate weighting |
US8160668B2 (en) | 2006-09-29 | 2012-04-17 | Nellcor Puritan Bennett Llc | Pathological condition detector using kernel methods and oximeters |
US20080081956A1 (en) | 2006-09-29 | 2008-04-03 | Jayesh Shah | System and method for integrating voice with a medical device |
US7848891B2 (en) | 2006-09-29 | 2010-12-07 | Nellcor Puritan Bennett Llc | Modulation ratio determination with accommodation of uncertainty |
US8175667B2 (en) | 2006-09-29 | 2012-05-08 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US7706896B2 (en) | 2006-09-29 | 2010-04-27 | Nellcor Puritan Bennett Llc | User interface and identification in a medical device system and method |
US20080082338A1 (en) * | 2006-09-29 | 2008-04-03 | O'neil Michael P | Systems and methods for secure voice identification and medical device interface |
US8068890B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Pulse oximetry sensor switchover |
US8728059B2 (en) | 2006-09-29 | 2014-05-20 | Covidien Lp | System and method for assuring validity of monitoring parameter in combination with a therapeutic device |
US20080097175A1 (en) * | 2006-09-29 | 2008-04-24 | Boyce Robin S | System and method for display control of patient monitor |
US8068891B2 (en) | 2006-09-29 | 2011-11-29 | Nellcor Puritan Bennett Llc | Symmetric LED array for pulse oximetry |
US7925511B2 (en) | 2006-09-29 | 2011-04-12 | Nellcor Puritan Bennett Llc | System and method for secure voice identification in a medical device |
US7698002B2 (en) | 2006-09-29 | 2010-04-13 | Nellcor Puritan Bennett Llc | Systems and methods for user interface and identification in a medical device |
US8690864B2 (en) | 2007-03-09 | 2014-04-08 | Covidien Lp | System and method for controlling tissue treatment |
US8265724B2 (en) | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
US8175665B2 (en) * | 2007-03-09 | 2012-05-08 | Nellcor Puritan Bennett Llc | Method and apparatus for spectroscopic tissue analyte measurement |
US20080221426A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | Methods and apparatus for detecting misapplied optical sensors |
US20080221416A1 (en) * | 2007-03-09 | 2008-09-11 | Nellcor Puritan Bennett Llc | System and method for detection of macular degeneration using spectrophotometry |
US8346327B2 (en) * | 2007-03-09 | 2013-01-01 | Covidien Lp | Method for identification of sensor site by local skin spectrum data |
US8280469B2 (en) | 2007-03-09 | 2012-10-02 | Nellcor Puritan Bennett Llc | Method for detection of aberrant tissue spectra |
US7876114B2 (en) | 2007-08-08 | 2011-01-25 | Cascade Microtech, Inc. | Differential waveguide probe |
JP4569615B2 (ja) * | 2007-09-25 | 2010-10-27 | ブラザー工業株式会社 | 印刷装置 |
US8204567B2 (en) * | 2007-12-13 | 2012-06-19 | Nellcor Puritan Bennett Llc | Signal demodulation |
US8092993B2 (en) | 2007-12-31 | 2012-01-10 | Nellcor Puritan Bennett Llc | Hydrogel thin film for use as a biosensor |
US20090171174A1 (en) * | 2007-12-31 | 2009-07-02 | Nellcor Puritan Bennett Llc | System and method for maintaining battery life |
US8275553B2 (en) | 2008-02-19 | 2012-09-25 | Nellcor Puritan Bennett Llc | System and method for evaluating physiological parameter data |
US8750953B2 (en) | 2008-02-19 | 2014-06-10 | Covidien Lp | Methods and systems for alerting practitioners to physiological conditions |
US8140272B2 (en) | 2008-03-27 | 2012-03-20 | Nellcor Puritan Bennett Llc | System and method for unmixing spectroscopic observations with nonnegative matrix factorization |
US8437822B2 (en) | 2008-03-28 | 2013-05-07 | Covidien Lp | System and method for estimating blood analyte concentration |
US8364224B2 (en) | 2008-03-31 | 2013-01-29 | Covidien Lp | System and method for facilitating sensor and monitor communication |
US8292809B2 (en) | 2008-03-31 | 2012-10-23 | Nellcor Puritan Bennett Llc | Detecting chemical components from spectroscopic observations |
US8112375B2 (en) | 2008-03-31 | 2012-02-07 | Nellcor Puritan Bennett Llc | Wavelength selection and outlier detection in reduced rank linear models |
WO2009137682A1 (en) | 2008-05-07 | 2009-11-12 | Lynn Lawrence A | Medical failure pattern search engine |
USD626562S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Triangular saturation pattern detection indicator for a patient monitor display panel |
US9895068B2 (en) | 2008-06-30 | 2018-02-20 | Covidien Lp | Pulse oximeter with wait-time indication |
USD626561S1 (en) | 2008-06-30 | 2010-11-02 | Nellcor Puritan Bennett Llc | Circular satseconds indicator and triangular saturation pattern detection indicator for a patient monitor display panel |
US8862194B2 (en) | 2008-06-30 | 2014-10-14 | Covidien Lp | Method for improved oxygen saturation estimation in the presence of noise |
US8094299B2 (en) * | 2008-07-24 | 2012-01-10 | Beckman Coulter, Inc. | Transducer module |
US8417309B2 (en) | 2008-09-30 | 2013-04-09 | Covidien Lp | Medical sensor |
US8386000B2 (en) | 2008-09-30 | 2013-02-26 | Covidien Lp | System and method for photon density wave pulse oximetry and pulse hemometry |
US8968193B2 (en) | 2008-09-30 | 2015-03-03 | Covidien Lp | System and method for enabling a research mode on physiological monitors |
US8433382B2 (en) | 2008-09-30 | 2013-04-30 | Covidien Lp | Transmission mode photon density wave system and method |
US7888957B2 (en) | 2008-10-06 | 2011-02-15 | Cascade Microtech, Inc. | Probing apparatus with impedance optimized interface |
WO2010051479A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System and method for facilitating observation of monitored physiologic data |
CA2741044A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System and method for facilitating observation of monitored physiologic data |
US8410806B2 (en) | 2008-11-21 | 2013-04-02 | Cascade Microtech, Inc. | Replaceable coupon for a probing apparatus |
US8319503B2 (en) | 2008-11-24 | 2012-11-27 | Cascade Microtech, Inc. | Test apparatus for measuring a characteristic of a device under test |
US8221319B2 (en) | 2009-03-25 | 2012-07-17 | Nellcor Puritan Bennett Llc | Medical device for assessing intravascular blood volume and technique for using the same |
US8509869B2 (en) | 2009-05-15 | 2013-08-13 | Covidien Lp | Method and apparatus for detecting and analyzing variations in a physiologic parameter |
US8494786B2 (en) | 2009-07-30 | 2013-07-23 | Covidien Lp | Exponential sampling of red and infrared signals |
US8494606B2 (en) | 2009-08-19 | 2013-07-23 | Covidien Lp | Photoplethysmography with controlled application of sensor pressure |
US8788001B2 (en) | 2009-09-21 | 2014-07-22 | Covidien Lp | Time-division multiplexing in a multi-wavelength photon density wave system |
US8494604B2 (en) | 2009-09-21 | 2013-07-23 | Covidien Lp | Wavelength-division multiplexing in a multi-wavelength photon density wave system |
US8704666B2 (en) | 2009-09-21 | 2014-04-22 | Covidien Lp | Medical device interface customization systems and methods |
US8923945B2 (en) * | 2009-09-24 | 2014-12-30 | Covidien Lp | Determination of a physiological parameter |
EP2480997A2 (de) * | 2009-09-24 | 2012-08-01 | Nellcor Puritan Bennett LLC | Bestimmung eines physiologischen parameters |
US8798704B2 (en) | 2009-09-24 | 2014-08-05 | Covidien Lp | Photoacoustic spectroscopy method and system to discern sepsis from shock |
US8571621B2 (en) * | 2009-09-24 | 2013-10-29 | Covidien Lp | Minimax filtering for pulse oximetry |
US8515511B2 (en) | 2009-09-29 | 2013-08-20 | Covidien Lp | Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same |
US8376955B2 (en) | 2009-09-29 | 2013-02-19 | Covidien Lp | Spectroscopic method and system for assessing tissue temperature |
US9066660B2 (en) | 2009-09-29 | 2015-06-30 | Nellcor Puritan Bennett Ireland | Systems and methods for high-pass filtering a photoplethysmograph signal |
US9554739B2 (en) | 2009-09-29 | 2017-01-31 | Covidien Lp | Smart cable for coupling a medical sensor to an electronic patient monitor |
US8401608B2 (en) * | 2009-09-30 | 2013-03-19 | Covidien Lp | Method of analyzing photon density waves in a medical monitor |
US8391943B2 (en) | 2010-03-31 | 2013-03-05 | Covidien Lp | Multi-wavelength photon density wave system using an optical switch |
US8498683B2 (en) | 2010-04-30 | 2013-07-30 | Covidien LLP | Method for respiration rate and blood pressure alarm management |
US8930145B2 (en) | 2010-07-28 | 2015-01-06 | Covidien Lp | Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring |
US9380982B2 (en) | 2010-07-28 | 2016-07-05 | Covidien Lp | Adaptive alarm system and method |
US8610769B2 (en) | 2011-02-28 | 2013-12-17 | Covidien Lp | Medical monitor data collection system and method |
US9833146B2 (en) | 2012-04-17 | 2017-12-05 | Covidien Lp | Surgical system and method of use of the same |
DE102017001484A1 (de) * | 2017-02-16 | 2018-08-16 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Anordnung zum Kalibrieren von Vorrichtungen zur Erkennung von Blut oder Blutbestandteilen in einer Flüssigkeit |
US10340408B1 (en) | 2018-05-17 | 2019-07-02 | Hi Llc | Non-invasive wearable brain interface systems including a headgear and a plurality of self-contained photodetector units configured to removably attach to the headgear |
US10420498B1 (en) | 2018-06-20 | 2019-09-24 | Hi Llc | Spatial and temporal-based diffusive correlation spectroscopy systems and methods |
US11213206B2 (en) | 2018-07-17 | 2022-01-04 | Hi Llc | Non-invasive measurement systems with single-photon counting camera |
WO2020131148A1 (en) | 2018-12-21 | 2020-06-25 | Hi Llc | Biofeedback for awareness and modulation of mental state using a non-invasive brain interface system and method |
CA3135228A1 (en) | 2019-05-06 | 2020-11-12 | Hi Llc | Photodetector architectures for time-correlated single photon counting |
CN113766871A (zh) | 2019-06-06 | 2021-12-07 | Hi有限责任公司 | 具有低功率的时间数字转换器架构的光电检测器系统 |
US11096620B1 (en) | 2020-02-21 | 2021-08-24 | Hi Llc | Wearable module assemblies for an optical measurement system |
US11771362B2 (en) | 2020-02-21 | 2023-10-03 | Hi Llc | Integrated detector assemblies for a wearable module of an optical measurement system |
US11883181B2 (en) | 2020-02-21 | 2024-01-30 | Hi Llc | Multimodal wearable measurement systems and methods |
US11950879B2 (en) | 2020-02-21 | 2024-04-09 | Hi Llc | Estimation of source-detector separation in an optical measurement system |
WO2021167876A1 (en) | 2020-02-21 | 2021-08-26 | Hi Llc | Methods and systems for initiating and conducting a customized computer-enabled brain research study |
WO2021167892A1 (en) | 2020-02-21 | 2021-08-26 | Hi Llc | Wearable devices and wearable assemblies with adjustable positioning for use in an optical measurement system |
US11187575B2 (en) | 2020-03-20 | 2021-11-30 | Hi Llc | High density optical measurement systems with minimal number of light sources |
WO2021188486A1 (en) | 2020-03-20 | 2021-09-23 | Hi Llc | Phase lock loop circuit based adjustment of a measurement time window in an optical measurement system |
WO2021188487A1 (en) | 2020-03-20 | 2021-09-23 | Hi Llc | Temporal resolution control for temporal point spread function generation in an optical measurement system |
US11245404B2 (en) | 2020-03-20 | 2022-02-08 | Hi Llc | Phase lock loop circuit based signal generation in an optical measurement system |
US11857348B2 (en) | 2020-03-20 | 2024-01-02 | Hi Llc | Techniques for determining a timing uncertainty of a component of an optical measurement system |
US11877825B2 (en) | 2020-03-20 | 2024-01-23 | Hi Llc | Device enumeration in an optical measurement system |
WO2021188485A1 (en) | 2020-03-20 | 2021-09-23 | Hi Llc | Maintaining consistent photodetector sensitivity in an optical measurement system |
WO2021188496A1 (en) | 2020-03-20 | 2021-09-23 | Hi Llc | Photodetector calibration of an optical measurement system |
US11864867B2 (en) | 2020-03-20 | 2024-01-09 | Hi Llc | Control circuit for a light source in an optical measurement system by applying voltage with a first polarity to start an emission of a light pulse and applying voltage with a second polarity to stop the emission of the light pulse |
CN113984663A (zh) * | 2021-10-28 | 2022-01-28 | 中国人民解放军海军特色医学中心 | 一种光学检测装置及其工作方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074428B1 (de) * | 1981-09-15 | 1987-04-08 | Arno Dr. Dipl.-Phys. Müller | Verfahren und Vorrichtung zur quantitativen Bestimmung gelöster Substanzen in Ein- und Mehrkomponentensystemen durch Laser-Lichtstreuung |
US5386819A (en) * | 1990-03-29 | 1995-02-07 | Olympus Optical Co., Ltd. | Method and apparatus for inhibiting a scattered component in a light having passed through an examined object |
US5664574A (en) * | 1991-01-22 | 1997-09-09 | Non-Invasive Technology, Inc. | System for tissue examination using directional optical radiation |
US6226540B1 (en) * | 1995-12-13 | 2001-05-01 | Peter Bernreuter | Measuring process for blood gas analysis sensors |
WO2002028274A1 (en) * | 2000-10-05 | 2002-04-11 | Cybro Medical Ltd. | A pulse oximeter and a method of its operation |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3511227A (en) * | 1967-02-27 | 1970-05-12 | Univ Utah | Measurement of blood flow using coherent radiation and doppler effect |
CA1037285A (en) * | 1975-04-30 | 1978-08-29 | Glenfield Warner | Ear oximetry process and apparatus |
US4679939A (en) * | 1985-12-23 | 1987-07-14 | The United States Of America As Represented By The Secretary Of The Air Firce | In situ small particle diagnostics |
US4805623A (en) * | 1987-09-04 | 1989-02-21 | Vander Corporation | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
US5178142A (en) * | 1989-05-23 | 1993-01-12 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
EP0613652B1 (de) * | 1990-02-15 | 1997-04-16 | Hewlett-Packard GmbH | Gerät und Verfahren zur nichtinvasiven Messung der Sauerstoffsättigung |
CA2092373A1 (en) * | 1992-04-24 | 1993-10-25 | Klaus W. Berndt | Methods and apparatus for detecting biological activities in a specimen |
TW275570B (de) * | 1994-05-05 | 1996-05-11 | Boehringer Mannheim Gmbh | |
DE4417639A1 (de) * | 1994-05-19 | 1995-11-23 | Boehringer Mannheim Gmbh | Verfahren zur Bestimmung eines Analyten in einer biologischen Probe |
DE19612425C2 (de) * | 1995-03-31 | 2000-08-31 | Nihon Kohden Corp | Apparat zur Messung von Hämoglobinkonzentration |
DE19651690C2 (de) * | 1995-12-13 | 2001-12-13 | Bernreuter Peter | Meßverfahren zur Bestimmung der Blutsauerstoffsättigung |
DE19609410C2 (de) * | 1996-03-04 | 2002-04-25 | Biotronik Mess & Therapieg | Vorrichtung zur Bestimmung der Blutsauerstoffsättigung |
DE69940053D1 (de) * | 1998-02-05 | 2009-01-22 | Hema Metrics Inc | Verfahren und vorrichtung zur nicht-invasiven beobachtung von blutbestandteilen |
JPH11244267A (ja) * | 1998-03-03 | 1999-09-14 | Fuji Photo Film Co Ltd | 血中成分濃度測定装置 |
US6064898A (en) | 1998-09-21 | 2000-05-16 | Essential Medical Devices | Non-invasive blood component analyzer |
JP3763687B2 (ja) * | 1998-12-25 | 2006-04-05 | 三井金属鉱業株式会社 | 血糖値測定装置 |
US6151517A (en) * | 1999-01-22 | 2000-11-21 | Futrex Inc. | Method and apparatus for noninvasive quantitative measurement of blood analytes |
US6522398B2 (en) * | 1999-02-08 | 2003-02-18 | Cme Telemetrix Inc. | Apparatus for measuring hematocrit |
AU3655700A (en) | 1999-04-16 | 2000-11-02 | Martin Koch | A non-invasive procedure and an apparatus for determining the hemoglobin contentof blood |
US6442411B1 (en) | 1999-04-21 | 2002-08-27 | Optix, Lp | Method for improving calibration of an instrument for non-invasively measuring constituents in arterial blood |
DE10015622A1 (de) * | 2000-03-29 | 2001-10-11 | Harald Behrens | Nicht-invasive optische Vorrichtung und Verfahren zur kontinuierlichen Erfassung der Blutflußdynamik, von Blutkomponenten und Blutvolumenanteilen im Gewebe/Haut des Menschen |
-
2002
- 2002-03-27 DE DE10213692A patent/DE10213692B4/de not_active Expired - Fee Related
-
2003
- 2003-02-08 CA CA002480260A patent/CA2480260A1/en not_active Abandoned
- 2003-02-08 WO PCT/DE2003/000372 patent/WO2003079899A1/de not_active Application Discontinuation
- 2003-02-08 AU AU2003206658A patent/AU2003206658A1/en not_active Abandoned
- 2003-02-08 EP EP03704301A patent/EP1487339A1/de not_active Withdrawn
- 2003-02-08 US US10/509,001 patent/US7095491B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0074428B1 (de) * | 1981-09-15 | 1987-04-08 | Arno Dr. Dipl.-Phys. Müller | Verfahren und Vorrichtung zur quantitativen Bestimmung gelöster Substanzen in Ein- und Mehrkomponentensystemen durch Laser-Lichtstreuung |
US5386819A (en) * | 1990-03-29 | 1995-02-07 | Olympus Optical Co., Ltd. | Method and apparatus for inhibiting a scattered component in a light having passed through an examined object |
US5664574A (en) * | 1991-01-22 | 1997-09-09 | Non-Invasive Technology, Inc. | System for tissue examination using directional optical radiation |
US6226540B1 (en) * | 1995-12-13 | 2001-05-01 | Peter Bernreuter | Measuring process for blood gas analysis sensors |
WO2002028274A1 (en) * | 2000-10-05 | 2002-04-11 | Cybro Medical Ltd. | A pulse oximeter and a method of its operation |
Also Published As
Publication number | Publication date |
---|---|
DE10213692B4 (de) | 2013-05-23 |
DE10213692A1 (de) | 2003-10-09 |
CA2480260A1 (en) | 2003-10-02 |
US7095491B2 (en) | 2006-08-22 |
EP1487339A1 (de) | 2004-12-22 |
AU2003206658A1 (en) | 2003-10-08 |
US20050168722A1 (en) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10213692B4 (de) | Verfahren zur Steuerung einer Vorrichtung und Vorrichtung zur Messung von Inhaltsstoffen im Blut | |
EP0659055B1 (de) | Verfahren und vorrichtung zur analyse von glucose in einer biologischen matrix | |
EP0892617B1 (de) | Erkennung von störsignalen bei der pulsoxymetrischen messung | |
EP0818682B1 (de) | Verfahren und Messanordnung zur optischen Bestimmung der totalen Hämoglobinkonzentration | |
DE69925825T2 (de) | Kupplung für faseroptisches oximeter mit anzeige der wellenlängenverschiebung | |
DE19651690C2 (de) | Meßverfahren zur Bestimmung der Blutsauerstoffsättigung | |
EP0726729B1 (de) | Verfahren und vorrichtung zur analyse von glucose in einer biologischen matrix | |
DE69721732T2 (de) | Vorrichtung zur multispektralen analyse bei der nichtinvasiven nir-spektroskopie | |
EP0603658B1 (de) | Verfahren zur in-vivo-Bestimmung einer optischen Eigenschaft des Kammerwassers des Auges | |
DE19537646C2 (de) | Verfahren und Vorrichtung zum Erkennen verfälschter Meßwerte in der Pulsoximetrie zur Messung der Sauerstoffsättigung | |
DE19612425C2 (de) | Apparat zur Messung von Hämoglobinkonzentration | |
DE69727776T2 (de) | Verfahren zum bestimmen der fraktionellen sauerstoffsaturation | |
DE60024836T2 (de) | Bilderzeugungsvorrichtung zur darstellung von konzentrationsverhältnissen | |
DE112004002988B4 (de) | Instrument zum nichtinvasiven Messen des Blutzuckerpegels | |
KR970700859A (ko) | 혈액 성분의 농도를 측정하기 위한 비 침투성 비 분광 광도 적외선 측정 방법(non-invasive non-spectrophotometric infrared measurement of blood analyte concentrations) | |
EP0555645A1 (de) | Einrichtung zum Erkennen von Karies an Zähnen | |
DE602004001794T2 (de) | Verfahren und Vorrichtung zur in vitro oder in vivo Messung der Konzentration einer Substanz | |
EP0175352A2 (de) | Verfahren und Anordnung zur schnellen Bestimmung der Parameter eines Probenmediums | |
DE60129332T2 (de) | System und verfahren für einen nicht invasiven selbstkalibrierenden sensor | |
DE102016109694A1 (de) | Sensorvorrichtung | |
DE3929294A1 (de) | Verfahren und messeinrichtung zur messung der dosis bzw. dosisleistung von kernstrahlung | |
DE102004017130B4 (de) | Verfahren zur Messung des Gefäßdurchmessers optisch zugänglicher Blutgefäße | |
DE4325529C2 (de) | Vorrichtung zum Bestimmen der Konzentration von Stoffen im Blut | |
EP0548027B1 (de) | Einrichtung zur spektralphotometrischen Analyse | |
DE19629342C2 (de) | Verfahren und Anordnung zur nicht-invasiven, transkutanen Bestimmung von Stoffkonzentrationen in Körpergeweben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003704301 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2480260 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10509001 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003704301 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |